saccharomyces boulardii and Reduced CDI Recurrence

Doses used in studies

Time to effect

Median: 10 days · IQR 10 days–10 days · Range 10 days–10 days — Reported in 1 of 1 study

Safety in these studies

adverse eventsNo significant difference
No significant differences were found in diarrheal outcomes, functional ability, or adverse events.
from: Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treat
adverse events (overall)No significant differenceNo significant differences were found in ... adverse events.
No significant differences were found in diarrheal outcomes, functional ability, or adverse events.
from: Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treat
Overall tolerabilityReported
No patients discontinued treatment due to intolerance.
from: Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treat
treatment discontinuation due to intoleranceReported
No patients discontinued treatment due to intolerance.
from: Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treat

1 of 1 paper

Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial.